Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 25,846Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Zydelig

PharmaCompass

01

Brand Name : Zydelig

Idelalisib

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Zydelig

arrow
Fi Europe 2024
Not Confirmed

Idelalisib

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 72

2019 Revenue in Millions : 103

Growth (%) : -30

blank

02

Brand Name : Zydelig

Idelalisib

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Zydelig

arrow
Fi Europe 2024
Not Confirmed

Idelalisib

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 62

2020 Revenue in Millions : 72

Growth (%) : -14

blank

03

Brand Name : Zydelig

Idelalisib

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Zydelig

arrow
Fi Europe 2024
Not Confirmed

Idelalisib

Main Therapeutic Indication : Oncology

Currency : USD

2015 Revenue in Millions : 23

2014 Revenue in Millions : 132

Growth (%) : 474%

blank

04

Brand Name : Zydelig

Idelalisib

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Zydelig

arrow
Fi Europe 2024
Not Confirmed

Idelalisib

Main Therapeutic Indication : Oncology

Currency : USD

2016 Revenue in Millions : 168

2015 Revenue in Millions : 132

Growth (%) : 27

blank

05

Brand Name : Zydelig

Idelalisib

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Zydelig

arrow
Fi Europe 2024
Not Confirmed

Idelalisib

Main Therapeutic Indication : Oncology

Currency : USD

2017 Revenue in Millions : 149

2016 Revenue in Millions : 168

Growth (%) : -11

blank

06

Brand Name : Zydelig

Idelalisib

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Zydelig

arrow
Fi Europe 2024
Not Confirmed

Idelalisib

Main Therapeutic Indication : Oncology

Currency : USD

2018 Revenue in Millions : 133

2017 Revenue in Millions : 149

Growth (%) : -11%

blank

07

Brand Name : Zydelig

Idelalisib

arrow
Fi Europe 2024
Not Confirmed

08

Brand Name : Zydelig

Idelalisib

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Zydelig

arrow
Fi Europe 2024
Not Confirmed

Idelalisib

Main Therapeutic Indication : Oncology

Currency : USD

2019 Revenue in Millions : 103

2018 Revenue in Millions : 133

Growth (%) : -23

blank